Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Is FOXO4-DRI Safe? Side Effects Comparison

Hepatotoxicity (elevated liver enzymes) Yes. Transient ALT/AST elevation Mild to moderate 48–72 hours Low. But chronic use unstudied Gastrointestinal disturbance Yes. Diarrhoea, reduced appetite Mild 24–48 hours Moderate. Gut turnover in humans is slower than

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Hepatotoxicity (elevated liver enzymes)
  • Yes. Transient ALT/AST elevation
  • Mild to moderate
  • 48–72 hours
  • Low. But chronic use unstudied
  • Gastrointestinal disturbance
  • Yes. Diarrhoea, reduced appetite
  • Mild
  • 24–48 hours
  • Moderate. Gut turnover in humans is slower than rodents
  • Immune suppression (WBC reduction)
  • Yes. At doses ≥10 mg/kg
  • Moderate
  • 10–14 days
  • Unknown. Dose-dependent, threshold unclear
  • Cardiovascular effects
  • Not reported
  • N/A
  • Unknown. No long-term monitoring conducted
  • Reproductive harm
  • Not studied
  • Unknown. No multi-generational studies exist
  • Neurotoxicity
  • Unknown. Behavioural assays not included in protocols